AeroVironment Delivers Q4 Double Beat, Shares Surge

AeroVironment Inc (NASDAQ:AVAV) reported financial results for the fourth quarter of fiscal 2026 after the market close on Monday. Here’s a look at the key details from the print. AeroVironment stock is showing upward movement. What’s pushing AVAV stock higher?...

AbbVie Reports Phase 3 EPCORE DLBCL-4 Results Showing Epcoritamab Combination Reduced Disease Progression Risk By Up To 60% In Relapsed Or Refractory DLBCL; Trial Met Its Primary Endpoint, Demonstrating Statistically Significant And Clinically Meaningful Improvement In Progression-Free Survival

Topline results from Phase 3 EPCORE® DLBCL-4 trial evaluating epcoritamab in combination with lenalidomide demonstrated statistically significant and clinically meaningful improvement in progression-free survival (PFS) in patients with relapsed or refractory (R/R)...